VSee Health enters USD 336,000 convertible note financing with Labrys

• VSee Health entered a securities purchase agreement with Labrys on June 30, 2026 for an unsecured convertible promissory note.
• Aggregate principal amount USD 336,000, including a USD 36,000 original issue discount; one-time 12% interest charge earned in full at issuance.
• Note matures on June 30, 2027; company can prepay before day 181, subject to a percentage-based cash repayment amount.
• Labrys can require up to 50% of cash proceeds received before repayment to be applied to repay outstanding principal and interest.
• Conversion allowed after certain triggers; conversion price set at 75% of the lowest closing bid in the prior 10 trading days, capped at 4.99% ownership.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VSee Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001185185-26-003211), on July 31, 2026, and is solely responsible for the information contained therein.